{
    "Trade/Device Name(s)": [
        "BD Veritor System for Rapid Detection of RSV"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K132456",
    "Predicate Device Reference 510(k) Number(s)": [
        "K101918"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GQG"
    ],
    "Summary Letter Date": "July 31, 2013",
    "Summary Letter Received Date": "August 14, 2013",
    "Submission Date": "October 23, 2013",
    "Regulation Number(s)": [
        "21 CFR 866.3480"
    ],
    "Regulation Name(s)": [
        "Respiratory syncytial virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Respiratory syncytial virus fusion protein"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Veritor System Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay",
        "Instrumented read",
        "Immunochromatographic"
    ],
    "Methodologies": [
        "Qualitative antigen detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for BD Veritor System for Rapid Detection of RSV using instrumented chromatographic immunoassay on nasopharyngeal swabs",
    "Indications for Use Summary": "For the direct and qualitative detection of RSV fusion protein from nasopharyngeal swabs in infants and pediatric patients under 6 years suspected of viral respiratory infection, to aid in diagnosis of RSV infection, used with BD Veritor System Reader.",
    "fda_folder": "Microbiology"
}